IDEXX Net Income From Continuing Ops from 2010 to 2026
| IX1 Stock | EUR 535.40 0.80 0.15% |
Net Income From Continuing Ops | First Reported 2016-12-31 | Previous Quarter 294 M | Current Value 274.6 M | Quarterly Volatility 65.9 M |
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Interest Expense of 24 M, Selling General Administrative of 765.7 M or Total Revenue of 2.8 B, as well as many indicators such as . IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
IDEXX | Net Income From Continuing Ops |
The Net Income From Continuing Ops trend for IDEXX Laboratories offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether IDEXX Laboratories is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest IDEXX Laboratories' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of IDEXX Laboratories over the last few years. It is IDEXX Laboratories' Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
IDEXX Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 452,493,774 | |
| Geometric Mean | 369,217,696 | |
| Coefficient Of Variation | 64.36 | |
| Mean Deviation | 250,927,734 | |
| Median | 377,047,000 | |
| Standard Deviation | 291,246,782 | |
| Sample Variance | 84824.7T | |
| Range | 839.1M | |
| R-Value | 0.88 | |
| Mean Square Error | 19630.8T | |
| R-Squared | 0.78 | |
| Slope | 51,036,638 | |
| Total Sum of Squares | 1357195T |
IDEXX Net Income From Continuing Ops History
About IDEXX Laboratories Financial Statements
IDEXX Laboratories stakeholders use historical fundamental indicators, such as IDEXX Laboratories' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although IDEXX Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in IDEXX Laboratories' assets and liabilities are reflected in the revenues and expenses on IDEXX Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 1 B | 540.3 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of IDEXX Laboratories Correlation against competitors. For more detail on how to invest in IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.